awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34251223-09E1E75D-DFEA-4FB4-90DA-D20ACE7385E2
Q34251223-09E1E75D-DFEA-4FB4-90DA-D20ACE7385E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34251223-09E1E75D-DFEA-4FB4-90DA-D20ACE7385E2
Lopinavir/r no longer recommended as a first-line regimen: a comparative effectiveness analysis.
P2860
Q34251223-09E1E75D-DFEA-4FB4-90DA-D20ACE7385E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34251223-09E1E75D-DFEA-4FB4-90DA-D20ACE7385E2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
21b05911c495043580179e4a6bfa7859c4a847fa
P2860
Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis.